doctor glp 1 How to Ask Your About GLP-1 Weight Loss Drugs 13 Questions to Ask Your
Description
GLP-1 agonists work by regulating appetite hormones and blood sugar, addressing both menopause-specific weight gain and metabolic slowdown
My take: GLP-1RAs may become more than metabolic drugs, but oncology needs prospective cancer-outcome data before calling this prevention
Eli Lilly and Novo Nordisk are preparing to take their rivalry to the next frontier of weight-loss medication: pills.
Little is known about the association of discontinuation of sodium-glucose cotransporter-2 (SGLT2) inhibitors and glucagon-like peptide-1 receptor agonists (GLP-1 RA) with outcomes in patients with CKD
A recent study links use of weight-loss drugs like Ozempic, Wegovy, Rybelsus, Trulicity, Mounjaro, or Zepbound to vision loss in patients.
Emerging evidence shows that GLP-1 RAs have potential benefits in patients with cancer
